We are thrilled to announce a brand-new podcast episode on SciPod global!
The GlioLighT Consortium continues to advance its ambitious exploration of 1267-nm light therapy for gliomas, pushing the boundaries of what laser therapy can achieve. In the latest SciPod episode, the team explains their methods and aims in an accessible, easy-to-understand format.
Beyond the technical advances, the episode emphasizes what makes GlioLighT unique: a tightly coordinated, cross-disciplinary approach that balances scientific rigor with visionary thinking. The consortium’s work is not just about immediate clinical translation; it’s about building a comprehensive evidence base that will inform future therapies for gliomas and potentially other neurological conditions.
As discussed in the podcast, the upcoming months will see the team consolidating key preclinical findings, refining laser prototypes, and exploring next-generation experimental setups—critical steps toward demonstrating the feasibility and safety of direct light therapy at the cellular level.
Catch the full discussion here: Lighting the Path: How the Gliolight Consortium is Exploring New Ways to Treat Brain Tumours
Follow us for more updates on LinkedIn: www.linkedin/company/gliolight
